TABLE 4.

Doses and durations used for examining the effects of various nanoparticles on lung disorders.

Nanoparticle	Dose	Duration
AgNPs: silver nanoparticles	8–128 μg/ml	1, 6, 24 h
AuNPs: gold nanoparticles	20, 100 μg/ml–5.00 mg/ml	24, 48, 72 h
Al2O3 NPs	0.4, 2 mg/ml	24 h
Carbon nanotubes	0.4–20 μg/ml	24 h
CdO NPs: cadmium oxide nanoparticles	1 μg/ml	24 h
CdSe: cadmium selenide	330 μl	24 h
CS: chitosan	5 μg/m–2.5 mg/ml	6 and 24 h
LCN: liquid crystalline NPs	10–50 μg/ml	12, 24, and 48 h
LPB: liposome-in-bacteria	0.62–5 μmol/L	24 h
NiO NPs: nickel oxide NPs	5 μg/ml–0.24 mg/kg	6 weeks
ONP-302-NPs	1 mg
QDs: quantum dots	5–20 μg/ml and 6 μg/kg	24 h
SBS: salbutamol sulfate	200 μg aerosolized	14 h
siRNA: small interfering RNA	5 μg–2.5 mg/kg	24 h and 3 days
SLN: solid lipid nanoparticles	30 µg/25 g/kg	1, 2, 3, and 6 days
TAC: tacrolimus	60 μg/mouse
ZnO: zinc oxide nanoparticle	10, 20, and 40 μg/ml

References were provided in the main text.